“…At present, C4-substituted pyrrolo/indolo[1,2- a ]quinoxalines are actively involved in various biomedicinal applications such as central 5-HT 3 receptor antagonists, D-loop activity of RAD51 inhibitors, antileishmanial, antimalarial, anticancer, and anti-HIV activities. Usually, a two-component condensation or oxidative cyclization reaction of N -(2-aminophenyl)pyrroles/indoles and a variety of carbonyl equivalents including aromatic aldehydes, aryl ketones, aryl acetic acids, pinacols, α-amino acids, benzyl amines, benzyl halides, styrenes, phenylacetylenes, dimethyl sulfoxide, α-carbonyl sulfonium ylide, and alkylboronic acids efficaciously constructs various C4-substituted pyrrolo/indolo[1,2- a ]quinoxalines. In 2015, Chen Ma et al reported p -TsOH-catalyzed unusual C–C bond cleavage of 1,3-diketones and β-keto esters to produce a series of 4-aryl/alkylpyrrolo/indolo[1,2- a ]quinoxalines (Scheme a) .…”